HOWL
Price
$2.26
Change
-$0.00 (-0.00%)
Updated
Nov 5, 04:00 PM (EDT)
2 days until earnings call
KYMR
Price
$47.66
Change
+$0.59 (+1.25%)
Updated
Nov 5, 04:00 PM (EDT)
107 days until earnings call
Ad is loading...

HOWL vs KYMR

Header iconHOWL vs KYMR Comparison
Open Charts HOWL vs KYMRBanner chart's image
Werewolf Therapeutics
Price$2.26
Change-$0.00 (-0.00%)
Volume$103.6K
CapitalizationN/A
Kymera Therapeutics
Price$47.66
Change+$0.59 (+1.25%)
Volume$21.45K
CapitalizationN/A
View a ticker or compare two or three
HOWL vs KYMR Comparison Chart
Loading...
HOWL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
HOWL vs. KYMR commentary
Nov 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HOWL is a Buy and KYMR is a Hold.

COMPARISON
Comparison
Nov 05, 2024
Stock price -- (HOWL: $2.27 vs. KYMR: $47.07)
Brand notoriety: HOWL and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HOWL: 115% vs. KYMR: 76%
Market capitalization -- HOWL: $98.99M vs. KYMR: $3.05B
HOWL [@Biotechnology] is valued at $98.99M. KYMR’s [@Biotechnology] market capitalization is $3.05B. The market cap for tickers in the [@Biotechnology] industry ranges from $498.83B to $0. The average market capitalization across the [@Biotechnology] industry is $2.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HOWL’s FA Score shows that 1 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • HOWL’s FA Score: 1 green, 4 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, HOWL is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HOWL’s TA Score shows that 3 TA indicator(s) are bullish while KYMR’s TA Score has 5 bullish TA indicator(s).

  • HOWL’s TA Score: 3 bullish, 7 bearish.
  • KYMR’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than HOWL.

Price Growth

HOWL (@Biotechnology) experienced а -23.48% price change this week, while KYMR (@Biotechnology) price change was -4.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.79%. For the same industry, the average monthly price growth was +15.00%, and the average quarterly price growth was +10.61%.

Reported Earning Dates

HOWL is expected to report earnings on Mar 20, 2025.

KYMR is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (+4.79% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($3.05B) has a higher market cap than HOWL($99M). KYMR YTD gains are higher at: 84.878 vs. HOWL (-41.321). HOWL has higher annual earnings (EBITDA): -47.75M vs. KYMR (-160.96M). KYMR has more cash in the bank: 550M vs. HOWL (135M). HOWL has less debt than KYMR: HOWL (36.7M) vs KYMR (88.2M). KYMR has higher revenues than HOWL: KYMR (87.6M) vs HOWL (9.28M).
HOWLKYMRHOWL / KYMR
Capitalization99M3.05B3%
EBITDA-47.75M-160.96M30%
Gain YTD-41.32184.878-49%
P/E RatioN/AN/A-
Revenue9.28M87.6M11%
Total Cash135M550M25%
Total Debt36.7M88.2M42%
TECHNICAL ANALYSIS
Technical Analysis
HOWLKYMR
RSI
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 21 days ago
81%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 6 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
HOWL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NDBKY17.390.33
+1.93%
Nedbank Group, Ltd.
NEXCF0.04N/A
+0.24%
NexTech3D.AI Corp.
BASFY12.18-0.09
-0.69%
BASF SE
FSNUY9.10-0.15
-1.62%
Fresenius SE & Co. KGaA
MDNAF1.70-0.11
-6.08%
Medicenna Therapeutics Corp.

HOWL and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOWL has been loosely correlated with GBIO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if HOWL jumps, then GBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOWL
1D Price
Change %
HOWL100%
-8.67%
GBIO - HOWL
41%
Loosely correlated
-1.81%
ABOS - HOWL
37%
Loosely correlated
+3.69%
GNPX - HOWL
37%
Loosely correlated
-6.05%
ALLO - HOWL
37%
Loosely correlated
+10.29%
KYMR - HOWL
35%
Loosely correlated
+1.29%
More

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with RXRX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+1.29%
RXRX - KYMR
50%
Loosely correlated
+3.44%
CRSP - KYMR
50%
Loosely correlated
-0.28%
BEAM - KYMR
49%
Loosely correlated
+6.24%
RCKT - KYMR
48%
Loosely correlated
-0.91%
RVMD - KYMR
47%
Loosely correlated
+1.42%
More